Pericardial effusion interventions

Revision as of 01:16, 9 December 2019 by Roukoz Abou Karam (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Pericardial effusion Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pericardial effusion from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Cardiac Catheterization

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Pericardial Window

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Pericardial effusion interventions On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Pericardial effusion interventions

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pericardial effusion interventions

CDC on Pericardial effusion interventions

Pericardial effusion interventions in the news

Blogs on Pericardial effusion interventions

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Pericardial effusion interventions

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Roukoz A. Karam, M.D.[2]

Overview

The mainstay of treatment for pericardial effusion is pericardial fluid drainage. Indications for pericardiocentesis or a pericardial window include cardiac tamponade, for diagnostic purposes if there is suspected purulent, tuberculosis, or neoplastic pericarditis, and the presence of a large, persistent, symptomatic pericardial effusion.

Indications

The mainstay of treatment for pericardial effusion is pericardiocentesis. Pericardiocentesis is usually reserved for patients with either:

  • a pericardial effusion and evidence of hemodynamic compromise (ie, cardiac tamponade)
    • Urgent drainage of the pericardial effusion for therapeutic (and potentially diagnostic) purposes.
  • a pericardial effusion who are hemodynamically stable with no evidence of cardiac tamponade
    • do not require immediate drainage of the effusion for therapeutic purposes
    • sampling of the effusion may be indicated for diagnostic purposes in patients without a clear etiology for the effusion

Indications for pericardiocentesis or a pericardial window include the following:[1]



References

  1. Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmuller R, Adler Y, Tomkowski WZ, Thiene G, Yacoub MH (2004). "Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European Society of Cardiology". Eur Heart J. 25 (7): 587–10. doi:10.1016/j.ehj.2004.02.002. PMID 15120056.